HYPHEN的动态

Curious about BHRT? Watch the video below to learn more about how it can benefit you! #kalefunctionalmedicine #holisticmedicine #bhrt #houstontx

Curious about BHRT? Watch the video below to learn more about how it can benefit you! #kalefunctionalmedicine #holisticmedicine #bhrt #houstontx

?????????? Five Star Review! Thank you for the kind words. We appreciate your business and look forward to working with you again. If you are in any need of IT support, do not hesitate to contact us. We are ready to help! #AiTechnologyProfessionals #Richmond #Virginia #RichmondBusiness

Check out the latest area that we're working on for ???????? ??????????: ????????????! We're looking forward to getting the game into your hands, in the near future. #puzzle #adventure #story #tile #tales #pirate #ninezyme

My social media feed has been full of news about the Oscars, but one pharmaceutical advertisement outside of the event caught my attention: Eli Lilly's "Big Night". Let's unpack several layers of marketing here: https://lnkd.in/es7bj5CQ. First, Eli Lilly used the Oscars as a platform to send their message. Rightly so after Jimmy Kimmel joked about Ozempic during the 2023 Oscars. Second, Eli Lilly targeted two groups: the famous (who may use GLP-1 Agonists) as a means of weight loss for "one night", and patients who struggle with weight loss and suffer from obesity long term. Third, note that Eli Lilly never mentions their product, Zepbound, or their competitor's, Ozempic / Wegovy (Novo Nordisk) in the ad, meaning it is an unbranded campaign. They are trying to change a part of the market. Typically celebrity endorsements of drugs are highly sought after in the pharmaceutical industry since it's an effective way to build brand awareness and trustworthiness, accelerating drug uptake from a new product launch. Here are 13 celebrities who've opened up about taking Ozempic or weight-loss drugs: https://lnkd.in/ezpx5Gig I suspect Eli Lily is taking a calculated marketing risk: to moderate the growth of GLP-1s, so that high-risk patients can access the drug. The result? Hopefully, a slight pause amidst the hype to remember the historical risks and challenges of weight loss medications, noting numerous failed attempts and unintended side effects throughout history. Dr. Bray and Dr. Pernell thoroughly detail these challenges in creating effective, safe anti-obesity drugs: https://lnkd.in/eJz-njbr One week ago, Novo Nordisk released their unbranded campaign "World Obesity Day" which focused on the community required to overcome obesity: https://lnkd.in/e2YcveDY. Familiar family-style scenes surround four silent patients. I'm curious: what do you think of these two ads? What resonates with you? Do you think Eli Lily made the right move, or should pharmaceutical marketers play it safe, like Novo Nordisk? #pharma #pharmamarketing #marketing

"On this auspicious occasion of Dussehra, may we conquer all challenges and emerge victorious in our personal and professional lives. ?? Just as Lord Ram triumphed over Ravana, let's embrace the power of good over evil and channel it toward success, growth, and innovation in every venture. Let's strive to build a future filled with positivity, strength, and excellence. Wishing everyone a happy and prosperous Dussehra! ??? #Dussehra2024 #VictoryOfGood #InnovationAndGrowth"

AlphaCino: Missed the surge? Reclaim your peak performance with our powerful blend. Enhance your focus, strength, and productivity. https://alphacino.com - - - - - #Alphacino #masculinitymastered #strength #selfimprovement #alphamale #achievemore #highvalueman

Want to learn about the new functionality coming to Bevica in the 2024 release wave 1 update? Join Claudio Martell, MBA for our 30-minute webinar on Wednesday, 1 May at 12pm to find out more. Register here: https://lnkd.in/ei4yFtVW #msdyn365bc #waveupdate #functionality #userexperience #bevica

Catailyst Regulatory Event Snippets: Drug Approval in a Country Approval in China Shanghai Kechow Pharma, Inc. China National Medical Products Administration Approval of Tunlametinib (HL-085), the first approved targeted therapy NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 #melanoma a potential best-in-class MEK inhibitor based on positive data from the pivotal Phase 2 study #Tunlametinib?is a small molecule inhibitor of Mitogen-activated protein kinase kinase (MEK)?

Eli Lilly's new ad at the Oscars, "Big Night," sends a clear message: Prescription medications for Type 2 diabetes and obesity aren't meant for vanity. The ad emphasizes that drugs like Mounjaro and Ozempic are intended for those whose health is affected by obesity, not for general weight loss or cosmetic purposes. What do you think of the message that Lilly is trying to send? Do you have any opinions or personal experiences regarding the 'misuse' of weight-loss drugs? Prescription drugs and 'Big Pharma' are often put into contention when regarding the use or distribution of certain drugs. Are there deeper, underlying issues that need to be tackled regarding this subject? What do you think? Link to Ad: https://lnkd.in/giMbNyqf #EliLilly #BigNight #PrescriptionMedication #ObesityAwareness #HealthcareDiscussion